Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (231-240 of 528) with videos related to

Pageof 53
Sort By:
Pulmonary Circulation|December 24, 2015
Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier functionPanfeng Fu, Peter V Usatyuk, Jeffrey Jacobson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103Charles M Rudin, Ravi Salgia, Xiaofei Wang, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2024
Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case seriesRamya Muddasani, Neel Talwar, Isa Mambetsariev, et al.
Plos One|March 6, 2014
Activating the expression of human K-rasG12D stimulates oncogenic transformation in transgenic goat fetal fibroblast cellsJianhua Gong, Zhongde Wang, Irina Polejaeva, et al.
Cancer Research|December 6, 2013
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancerIchiro Kawada, Rifat Hasina, Qudsia Arif, et al.
Oncotarget|July 26, 2018
Heuristic value-based framework for lung cancer decision-makingIsa Mambetsariev, Rebecca Pharaon, Arin Nam, et al.
The Journal of Biological Chemistry|August 19, 2007
CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactinPatrick A Singleton, Ravi Salgia, Liliana Moreno-Vinasco, et al.
Expert Opinion on Therapeutic Targets|March 20, 2013
TLR3 agonists and proinflammatory antitumor activitiesSherven Sharma, Li Zhu, Michael Davoodi, et al.
Journal of Clinical Medicine|March 10, 2022
Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung CancerIsa Mambetsariev, Leonidas Arvanitis, Jeremy Fricke, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|December 21, 2011
MET and phosphorylated MET as potential biomarkers in lung cancerMaria Tretiakova, April K S Salama, Theodore Karrison, et al.
Pageof 53

Showing results (231-240 of 528) with videos related to

Sort By:
Pageof 53
Pulmonary Circulation|December 24, 2015
Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier functionPanfeng Fu, Peter V Usatyuk, Jeffrey Jacobson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103Charles M Rudin, Ravi Salgia, Xiaofei Wang, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2024
Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case seriesRamya Muddasani, Neel Talwar, Isa Mambetsariev, et al.
Plos One|March 6, 2014
Activating the expression of human K-rasG12D stimulates oncogenic transformation in transgenic goat fetal fibroblast cellsJianhua Gong, Zhongde Wang, Irina Polejaeva, et al.
Cancer Research|December 6, 2013
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancerIchiro Kawada, Rifat Hasina, Qudsia Arif, et al.
Oncotarget|July 26, 2018
Heuristic value-based framework for lung cancer decision-makingIsa Mambetsariev, Rebecca Pharaon, Arin Nam, et al.
The Journal of Biological Chemistry|August 19, 2007
CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactinPatrick A Singleton, Ravi Salgia, Liliana Moreno-Vinasco, et al.
Expert Opinion on Therapeutic Targets|March 20, 2013
TLR3 agonists and proinflammatory antitumor activitiesSherven Sharma, Li Zhu, Michael Davoodi, et al.
Journal of Clinical Medicine|March 10, 2022
Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung CancerIsa Mambetsariev, Leonidas Arvanitis, Jeremy Fricke, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|December 21, 2011
MET and phosphorylated MET as potential biomarkers in lung cancerMaria Tretiakova, April K S Salama, Theodore Karrison, et al.
Pageof 53